Effects of entinostat onresistance to cetuximab and EGFR TKIs in non-small cell lung cancer

被引：0
|
作者：
Witta, Samir E.
Chan, Dan
Girard, Luc
Zheng, Di
Franekova, Veronica
Peyton, Michael
Zhang, Zhi-Yong
Kline, Zoe
Minna, John D.
Bunn, Paul A.
Hirsch, Fred R.
机构：
[1] Mt Blue Canc Care Ctr, Golden, CO USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
[4] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18077
引用
收藏
页数：1
相关论文
共 50 条
  • [41] CANCER STEM CELL-LIKE POPULATION FROM NON-SMALL CELL LUNG CANCER IS PREFERENTIALLY SUPPRESSED BY EGFR-TKIS
    Zhou, Qinghua
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S465 - S465
  • [42] Cetuximab combination with chemotherapy in advanced non-small cell lung cancer
    Duan, Jian-chun
    Yang, Lu
    Wang, Jie
    Zhao, Jun
    Wu, Mei-na
    An, Tong-tong
    CHINESE JOURNAL OF CANCER RESEARCH, 2009, 21 (04) : 265 - 271
  • [43] Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?
    Sgambato, Assunta
    Casaluce, Francesca
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    JOURNAL OF THORACIC DISEASE, 2014, 6 (06) : 578 - 580
  • [44] Is more the better?-cetuximab in non-small cell lung cancer patients
    Moran, Teresa
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 : S195 - S197
  • [45] Relative Abundance of EGFR Mutations Predict Tumor Metastasis and EGFR-TKIs Prognosis in Patients with Non-Small Cell Lung Cancer
    Wang, Qiming
    Wang, Hongyan
    Tang, Hong
    Wu, Yufeng
    He, Zhen
    Wang, Lili
    Zhang, Zhe
    Zhao, Dongdong
    Yang, Li
    Wei, Bing
    Ma, Jie
    Guo, Yongjun
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S496 - S496
  • [46] Cetuximab Combination with Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Jian-chun Duan~*
    Chinese Journal of Cancer Research, 2009, 21 (04) : 265 - 271
  • [47] Concurrent gene alterations with EGFR mutation and treatment efficacy of EGFR-TKIs in Chinese patients with non-small cell lung cancer
    Hu, Wentao
    Liu, Yahui
    Chen, Jian
    ONCOTARGET, 2017, 8 (15) : 25046 - 25054
  • [48] Association of epithelial to mesenchymal transition with efficacy of EGFR-TKIs in non-small cell lung cancer patients with EGFR wild type
    Ren, Shengxiang
    Su, ChunXia
    Chen, Xiaoxia
    Li, Jiayu
    Li, Bing
    Li, Xuefei
    Zhou, Caicun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Relative abundance of EGFR mutations predict tumor metastasis and EGFR-TKIs prognosis in patients with non-small cell lung cancer
    Zhen, H.
    Wang, Q.
    Wang, H.
    Tang, H.
    Zhang, Z.
    Wu, Y.
    Wang, L.
    Zhao, D.
    Yang, L.
    Wei, B.
    Ma, J.
    Guo, Y.
    ANNALS OF ONCOLOGY, 2016, 27
  • [50] EGFR Mutation Testing in Non-Small Cell Lung Cancer
    Sriram, Krishna B.
    Francis, Santiyagu M. Savarimuthu
    Tan, Maxine E.
    Bowman, Rayleen V.
    Yang, Ian A.
    Fong, Kwun M.
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2010, 6 (04) : 310 - 321
12345